Filing Details

Accession Number:
0000899243-21-024505
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-06-17 18:41:13
Reporting Period:
2021-06-15
Accepted Time:
2021-06-17 18:41:13
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1563577 Galera Therapeutics Inc. GRTX Pharmaceutical Preparations (2834) 461454898
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1805257 Linda West C/O Galera Therapeutics, Inc.,
2 W Liberty Blvd #100
Malvern PA 19355
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-06-15 10,000 $9.13 40,000 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Acquisiton 2021-06-16 9,888 $0.00 9,888 $8.90
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
9,888 2031-06-15 No 4 A Direct
Footnotes
  1. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $9.01 to $9.23, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
  2. This option shall vest and become exercisable on the earlier of June 16, 2022 or the day immediately prior to the date of the Issuer's next annual meeting of stockholders occurring after the date of grant, in either case subject to the Reporting Person continuing in service on the Board as a Non-Employee Director through such vesting date.